Expanding oncology pharmacist teams: Justifying the return on investment

J Oncol Pharm Pract. 2022 Sep;28(6):1381-1387. doi: 10.1177/10781552221086292. Epub 2022 Mar 11.

Abstract

Oncology pharmacists are an integral member of the cancer care multi-disciplinary team. Despite the role being previously well defined, responsibilities continue to expand. Position justification for pharmacists is a challenge with prerequisites to optimize efficient processes, promote quality and reduce overall costs. Initiation and implementation of new oncology pharmacist services requires a clear description of value to the organization and a strong understanding of workflows. Position justifications must be data-driven and unique to the organization's need and should include physician or key stakeholder support, quality initiatives, cost-savings initiatives, and revenue-generating roles. The cases and examples described serve as a reference for individuals, teams, or organizations pursuing the value of a financial investment of an oncology pharmacist to expand or initiate new pharmacy services.

Keywords: Oncology; pharmacist; pharmacy; practice management.

MeSH terms

  • Cost Savings
  • Humans
  • Medical Oncology
  • Patient Care Team
  • Pharmaceutical Services*
  • Pharmacists
  • Physicians*
  • Professional Role